IMCD (OTCMKTS:IMCDY – Get Free Report) was the recipient of a significant drop in short interest during the month of September. As of September 30th, there was short interest totaling 239 shares, a drop of 95.3% from the September 15th total of 5,092 shares. Based on an average daily trading volume, of 12,222 shares, the short-interest ratio is presently 0.0 days.
IMCD Price Performance
IMCD stock traded up $1.04 during midday trading on Friday, reaching $56.42. 2,218 shares of the stock traded hands, compared to its average volume of 57,293. The stock’s fifty day moving average is $55.77 and its 200-day moving average is $53.16. IMCD has a 12 month low of $39.76 and a 12 month high of $61.56.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of IMCD in a research report on Thursday, July 30th. UBS Group upgraded shares of IMCD to a “buy” rating in a report on Tuesday, July 14th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, IMCD currently has a consensus rating of “Moderate Buy” and an average price target of $72.50.
IMCD Company Profile
IMCD N.V. is a global distributor and formulator of specialty chemicals and food ingredients. The company connects manufacturers of chemical products and ingredients with customers across a range of industries, providing sourcing, technical support, formulation assistance and supply-chain services.
Its products serve markets including coatings and construction, advanced materials, lubricants and fuels, personal care, pharmaceuticals, food and nutrition, and home care. IMCD also operates application laboratories and technical centers that help customers develop and adapt formulations for specific applications and regulatory requirements.
Founded in Rotterdam in 1995, IMCD has expanded through organic growth and acquisitions into a global business serving customers and suppliers across Europe, the Middle East and Africa, the Americas, and the Asia-Pacific region.
See Also
- Five stocks we like better than IMCD
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for IMCD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMCD and related companies with MarketBeat.com's FREE daily email newsletter.
